Disclosure Panels Details Page
Head and Neck Cancers Panel - Disclosures as of 06/30/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Douglas Adkins MD | astrazeneca BeiGene Blueprint Medicines Bristol Myers Squibb Celgene Corporation Celldex Therapeutics CUE Biosciences Debio Eisai Inc. Eli Lilly and Company Exelixis Inc. Gilead Sciences, Inc. Hookipa Pharma Inc Isa Therapeutics kura Kura Oncology, Inc. Merck & Co., Inc. Pfizer Inc. Roche Laboratories, Inc. Rubius |
Blueprint Medicines boerhinger ingelheim Coherus Biosciences Eisai Inc. Exelixis Inc. Immunitas Kura Oncology, Inc. Merck & Co., Inc. ppd Xilio |
None | None | ✔ |
| Andrew Birkeland MD | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| David Brizel MD | Biomimetix | KM Pharmaceutical Consulting | None | None | ✔ |
| Paul Busse MD, PhD | None | None | None | None | ✔ |
| Jimmy Caudell MD, PhD | Varian Medical Systems, Inc. | Galera | None | None | ✔ |
| Anthony Cmelak MD | None | None | None | None | ✔ |
| A. Dimitrios Colevas MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP atara Audro Biotech BeiGene Bristol Myers Squibb Cell Sight cellsight COTA Inc. cue biopharma cullinan Exelixis Inc. Gilead Sciences, Inc. Innate innate pharma iqvia Keyquest LOXO Oncology pds biotechnology corporation Pfizer Inc. PRA health sciences rakuten tessa Threshold Pharmaceuticals viracta |
None | None | None | ✔ |
| Eileen Cucinotta | None | None | None | None | - |
| Susan Darlow PhD | None | None | None | None | ✔ |
| Carole Fakhry MD, MPH | Merck & Co., Inc. | None | None | None | ✔ |
| Thomas Galloway MD | None | None | None | None | ✔ |
| Jessica Geiger MD | Alkermes Debio Exelixis Inc. Genentech, Inc. Regeneron Pharmaceuticals, Inc. |
Exelixis Inc. Merck & Co., Inc. Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Maura Gillison MD, PhD | Agenus BioMimetix BioNTech AG Bristol Myers Squibb Cullinan Genentech, Inc. Genocea Biosciences Gilead Sciences, Inc. Kura Oncology, Inc. |
Bayer HealthCare Bicara Therapeutics BioNTech Coherus BioSciences Debiopharm Eisai Inc. EMD Serono Ipsen Istari Oncology LLX Solutions, LLC Merck & Co., Inc. Mirati Therapeutics Nektar Therapeutics Roche Laboratories, Inc. Seagen Sensei Shattuck Labs |
None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | ✔ |
| Robert Haddad MD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Genentech, Inc. GSK Kura Oncology, Inc. Merck & Co., Inc. Pfizer Inc. |
Achilles AstraZeneca Pharmaceuticals LP Bayer HealthCare BioNTech Boehringer Ingelheim GmbH Bristol Myers Squibb Celgene Corporation Coherus Eisai Inc. Genentech, Inc. Gilead Sciences, Inc. GSK instil bio IO Biotech Kura Oncology, Inc. Merck & Co., Inc. Mirati Vaccinex |
isa nanobiotix |
None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Laura Hanisch PsyD | None | None | None | None | - |
| Kyle Herrmann BSN, RN, OCN | None | None | None | None | - |
| Wesley Hicks, Jr. MD | Tactiva (start up Biotechnology Firm) | None | None | None | - |
| Ying Hitchcock MD | None | CASTLE BIOSCIENCES | None | None | ✔ |
| Anne Holbrook PharmD, BCOP | None | None | None | None | ✔ |
| Antonio Jimeno MD, PhD | Bristol Myers Squibb Cantargia Debiopharma Genocea Iovance Khar Merck & Co., Inc. Moderna sanofi-aventis U.S. SQZ |
None | None | Champions Oncology, Inc.|SuviCa | ✔ |
| Debra Leizman MD | None | None | None | None | ✔ |
| Megan Lyons MS | None | None | None | None | ✔ |
| Ellie Maghami MD, FACS | None | None | None | None | ✔ |
| Nicole McMillian MS | None | None | None | None | ✔ |
| Loren Mell MD | AstraZeneca Pharmaceuticals LP Merck & Co., Inc. |
Cel-Sci | None | None | ✔ |
| Bharat Mittal MD | None | None | None | None | ✔ |
| David Pfister MD | AstraZeneca Pharmaceuticals LP Atara GSK Hookipa MedImmune Inc. Meira Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | None | ✔ |
| Harlan Pinto MD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| James Rocco MD, PhD | None | None | None | UPTODATE | ✔ |
| Cristina Rodriguez MD | Acerta Pharma AstraZeneca Pharmaceuticals LP Ayala Bayer HealthCare BeiGene Bristol Myers Squibb DeNovo Genentech, Inc. Incyte Corporation Kura Oncology, Inc. Merck & Co., Inc. Pharmacyclics Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. |
AbbVie, Inc. ADC AstraZeneca Pharmaceuticals LP BeiGene Coherus Biosciences Cue Biopharma Incyte Corporation Karyopharm Therapeutics Kite Pharma Millennium Pharmaceuticals, Inc. |
None | None | ✔ |
| Panayiotis Savvides MD, PhD | None | None | None | None | ✔ |
| David Schwartz MD | None | None | None | None | ✔ |
| Jatin Shah MD, PhD | None | None | None | None | ✔ |
| David Sher MD, MPH | Varian Medical Systems, Inc. | None | None | None | ✔ |
| Sharon Spencer MD | None | None | None | None | ✔ |
| Maie St. John MD, PhD | None | None | None | None | - |
| He Wang MD, PhD | None | None | None | None | ✔ |
| Gregory Weinstein MD | None | None | None | Olympus Corporation | ✔ |
| Francis Worden MD | Soligenix | Bristol Myers Squibb CUE Biopharma Eisai Eli Lilly and Company Exelixis Inc. Kura Oncology, Inc. LOXO Merck & Co., Inc. Oragenics Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Justine Yang Bruce MD | Astellas Pharma US, Inc. Cellectar Biosciences Incyte Corporation Kura Oncology, Inc. Lilly Merck & Co., Inc. Nektar Therapeutics Seattle Genetics, Inc. Sensei |
Genzyme Corporation Ideaya Istari Kura Oncology, Inc. OncLiv Phoenix Solutions |
None | None | ✔ |
| Sue Yom MD, PhD | BioMimetix Bristol Myers Squibb EMD Serono Genentech, Inc. Merck & Co., Inc. |
None | None | Springer|UpToDate | ✔ |
| Weining Zhen MD | None | None | None | None | ✔ |